HBW Insight speaks exclusively to CBD vape start-up Infused Amphora about the firm's recent UK market entry, the power of natural terpenes, the challenge of navigating the EU's complex regulatory landscape and how to reach consumers during a pandemic.
An estimated 7.3m people use CBD in the UK every year, according to cannabis market researchers, Prohibition Partners.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.
Bayer Consumer Health hopes its new InflammAge saliva-based biomarker can help “revolutionize self-care and how people can manage their aging journey.”
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Biotech identifying and stabilizing RNA compounds that can be incorporated into dietary supplements will receive mentorship, strategy guidance and technical support from experts at Nestlé Health Science.
Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.
France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.
Azelis adds dietary supplement ingredients and a large customer base across Spain to its portfolio with the acquisition of Solchem Nature.
